India Anti-Fungal Drugs Market Size, Share, Trends and Forecast by Drug Class, Indication, Infection Type, Route of Administration, Distribution Channel, End User, and Region, 2025-2033

India Anti-Fungal Drugs Market Size, Share, Trends and Forecast by Drug Class, Indication, Infection Type, Route of Administration, Distribution Channel, End User, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A31384

1   Preface
2    Scope and Methodology

2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3    Executive Summary
4    India Anti-Fungal Drugs Market - Introduction

4.1    Overview
4.2    Market Dynamics
4.3    Industry Trends
4.4    Competitive Intelligence
5    India Anti-Fungal Drugs Market Landscape
5.1    Historical and Current Market Trends (​2019-2024​)
5.2    Market Forecast (​2025-2033​)
6    India Anti-Fungal Drugs Market - Breakup by Drug Class
6.1    Azoles
6.1.1    Overview
6.1.2    Historical and Current Market Trends (​2019-2024​)
6.1.3    Market Forecast (​2025-2033​)
6.2    Echinocandins
6.2.1    Overview
6.2.2    Historical and Current Market Trends (​2019-2024​)
6.2.3    Market Forecast (​2025-2033​)
6.3    Polyenes
6.3.1    Overview
6.3.2    Historical and Current Market Trends (​2019-2024​)
6.3.3    Market Forecast (​2025-2033​)
6.4    Allylamines
6.4.1    Overview
6.4.2    Historical and Current Market Trends (​2019-2024​)
6.4.3    Market Forecast (​2025-2033​)
6.5    Others
6.5.1    Overview
6.5.2    Historical and Current Market Trends (​2019-2024​)
6.5.3    Market Forecast (​2025-2033​)
7    India Anti-Fungal Drugs Market - Breakup by Indication
7.1    Candidiasis
7.1.1    Overview
7.1.2    Historical and Current Market Trends (​2019-2024​)
7.1.3    Market Forecast (​2025-2033​)
7.2    Aspergillosis
7.2.1    Overview
7.2.2    Historical and Current Market Trends (​2019-2024​)
7.2.3    Market Forecast (​2025-2033​)
7.3    Dermatophytosis
7.3.1    Overview
7.3.2    Historical and Current Market Trends (​2019-2024​)
7.3.3    Market Forecast (​2025-2033​)
7.4    Mucormycosis
7.4.1    Overview
7.4.2    Historical and Current Market Trends (​2019-2024​)
7.4.3    Market Forecast (​2025-2033​)
7.5    Others
7.5.1    Historical and Current Market Trends (​2019-2024​)
7.5.2    Market Forecast (​2025-2033​)
8    India Anti-Fungal Drugs Market - Breakup by Infection Type
8.1    Superficial Fungal Infection
8.1.1    Overview
8.1.2    Historical and Current Market Trends (​2019-2024​)
8.1.3    Market Forecast (​2025-2033​)
8.2    Systemic Fungal Infection
8.2.1    Overview
8.2.2    Historical and Current Market Trends (​2019-2024​)
8.2.3    Market Forecast (​2025-2033​)
9    India Anti-Fungal Drugs Market - Breakup by Route of Administration
9.1    Parenteral
9.1.1    Overview
9.1.2    Historical and Current Market Trends (​2019-2024​)
9.1.3    Market Forecast (​2025-2033​)
9.2    Topical
9.2.1    Overview
9.2.2    Historical and Current Market Trends (​2019-2024​)
9.2.3    Market Forecast (​2025-2033​)
9.3    Oral
9.3.1    Overview
9.3.2    Historical and Current Market Trends (​2019-2024​)
9.3.3    Market Forecast (​2025-2033​)
9.4    Others
9.4.1    Historical and Current Market Trends (​2019-2024​)
9.4.2    Market Forecast (​2025-2033​)
10    India Anti-Fungal Drugs Market - Breakup by Distribution Channel
10.1    Retail Pharmacy
10.1.1    Overview
10.1.2    Historical and Current Market Trends (​2019-2024​)
10.1.3    Market Forecast (​2025-2033​)
10.2    Hospital Pharmacy
10.2.1    Overview
10.2.2    Historical and Current Market Trends (​2019-2024​)
10.2.3    Market Forecast (​2025-2033​)
10.3    Online Pharmacy
10.3.1    Overview
10.3.2    Historical and Current Market Trends (​2019-2024​)
10.3.3    Market Forecast (​2025-2033​)
11    India Anti-Fungal Drugs Market - Breakup by End User
11.1    Homecare
11.1.1    Overview
11.1.2    Historical and Current Market Trends (​2019-2024​)
11.1.3    Market Forecast (​2025-2033​)
11.2    Hospitals and Clinics
11.2.1    Overview
11.2.2    Historical and Current Market Trends (​2019-2024​)
11.2.3    Market Forecast (​2025-2033​)
11.3    Others
11.3.1    Historical and Current Market Trends (​2019-2024​)
11.3.2    Market Forecast (​2025-2033​)
12    India Anti-Fungal Drugs Market – Breakup by Region 
12.1    North India
12.1.1    Overview
12.1.2    Historical and Current Market Trends (​2019-2024​)
12.1.3    Market Breakup by Drug Class
12.1.4    Market Breakup by Indication
12.1.5    Market Breakup by Infection Type
12.1.6    Market Breakup by Route of Administration
12.1.7    Market Breakup by Distribution Channel
12.1.8    Market Breakup by End User
12.1.9    Key Players
12.1.10    Market Forecast (​2025-2033​)
12.2    South India
12.2.1    Overview
12.2.2    Historical and Current Market Trends (​2019-2024​)
12.2.3    Market Breakup by Drug Class
12.2.4    Market Breakup by Indication
12.2.5    Market Breakup by Infection Type
12.2.6    Market Breakup by Route of Administration
12.2.7    Market Breakup by Distribution Channel
12.2.8    Market Breakup by End User
12.2.9    Key Players
12.2.10    Market Forecast (​2025-2033​)
12.3    East India
12.3.1    Overview
12.3.2    Historical and Current Market Trends (​2019-2024​)
12.3.3    Market Breakup by Drug Class
12.3.4    Market Breakup by Indication
12.3.5    Market Breakup by Infection Type
12.3.6    Market Breakup by Route of Administration
12.3.7    Market Breakup by Distribution Channel
12.3.8    Market Breakup by End User
12.3.9    Key Players
12.3.10    Market Forecast (​2025-2033​)
12.4    West India
12.4.1    Overview
12.4.2    Historical and Current Market Trends (​2019-2024​)
12.4.3    Market Breakup by Drug Class
12.4.4    Market Breakup by Indication
12.4.5    Market Breakup by Infection Type
12.4.6    Market Breakup by Route of Administration
12.4.7    Market Breakup by Distribution Channel
12.4.8    Market Breakup by End User
12.4.9    Key Players
12.4.10    Market Forecast (​2025-2033​)
13    India Anti-Fungal Drugs Market – Competitive Landscape
13.1    Overview
13.2    Market Structure
13.3    Market Player Positioning
13.4    Top Winning Strategies
13.5    Competitive Dashboard
13.6    Company Evaluation Quadrant
14    Profiles of Key Players
14.1    Company A 
14.1.1    Business Overview
14.1.2    Products Offered
14.1.3    Business Strategies
14.1.4    SWOT Analysis
14.1.5    Major News and Events
14.2    Company B
14.2.1    Business Overview
14.2.2    Products Offered
14.2.3    Business Strategies
14.2.4    SWOT Analysis
14.2.5    Major News and Events
14.3    Company C
14.3.1    Business Overview
14.3.2    Products Offered
14.3.3    Business Strategies
14.3.4    SWOT Analysis
14.3.5    Major News and Events
14.4    Company D 
14.4.1    Business Overview
14.4.2    Products Offered
14.4.3    Business Strategies
14.4.4    SWOT Analysis
14.4.5    Major News and Events
14.5    Company E
14.5.1    Business Overview
14.5.2    Products Offered
14.5.3    Business Strategies
14.5.4    SWOT Analysis
14.5.5    Major News and Events    

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

15    India Anti-Fungal Drugs Market - Industry Analysis
15.1    Drivers, Restraints, and Opportunities
15.1.1    Overview
15.1.2    Drivers
15.1.3    Restraints
15.1.4    Opportunities
15.2    Porters Five Forces Analysis
15.2.1    Overview
15.2.2    Bargaining Power of Buyers
15.2.3    Bargaining Power of Suppliers
15.2.4    Degree of Competition
15.2.5    Threat of New Entrants
15.2.6    Threat of Substitutes
15.3    Value Chain Analysis
16    Appendix

India Anti-Fungal Drugs Market Size, Share, Trends and Forecast by Drug Class, Indication, Infection Type, Route of Administration, Distribution Channel, End User, and Region, 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials